Market Value834,374,475
Total Holdings57
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
JSPR / Jasper Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
EYPT / EyePoint Pharmaceuticals, Inc.
GOSS / Gossamer Bio, Inc.
TNYA / Tenaya Therapeutics, Inc.
VINC / Vincerx Pharma, Inc.
AVBP / ArriVent BioPharma, Inc.
DNTH / Dianthus Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
APLS / Apellis Pharmaceuticals, Inc. Call
INSM / Insmed Incorporated
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
CRBP / Corbus Pharmaceuticals Holdings, Inc.
NUVB / Nuvation Bio Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
CABA / Cabaletta Bio, Inc.
IMVT / Immunovant, Inc.
ALLO / Allogene Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
SANA / Sana Biotechnology, Inc.
APLS / Apellis Pharmaceuticals, Inc.
VERU / Veru Inc.
AVTE / Aerovate Therapeutics, Inc.
RAPT / RAPT Therapeutics, Inc.
RPHM / Reneo Pharmaceuticals, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
VTYX / Ventyx Biosciences, Inc.
CYTK / Cytokinetics, Incorporated
ANAB / AnaptysBio, Inc.
AKRO / Akero Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
PEPG / PepGen Inc.
GLYC / GlycoMimetics, Inc.
IPSC / Century Therapeutics, Inc.
MLYS / Mineralys Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
RCUS / Arcus Biosciences, Inc.
/ JASPER THERAPEUTICS INC
ROIV / Roivant Sciences Ltd.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
MIRM / Mirum Pharmaceuticals, Inc.
ACRS / Aclaris Therapeutics, Inc.
CBAY / CymaBay Therapeutics, Inc.
INZY / Inozyme Pharma, Inc.
CLDX / Celldex Therapeutics, Inc.
PRAX / Praxis Precision Medicines, Inc.
ATYR / aTyr Pharma, Inc.
TSHA / Taysha Gene Therapies, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
XLO / Xilio Therapeutics, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
DYN / Dyne Therapeutics, Inc.
MNMD / Mind Medicine (MindMed) Inc.
HLXB / Helix Acquisition Corp. II
CYBN / Cybin Inc.
PSTX / Poseida Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
ANNX / Annexon, Inc.
OCUL / Ocular Therapeutix, Inc.
ANTX / AN2 Therapeutics, Inc.
ISR / Perspective Therapeutics Inc
NKTX / Nkarta, Inc.
ALVR / AlloVir, Inc.
ACET / Adicet Bio, Inc.